Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
HE

WKN: A41F4V | ISIN: US42238D1072 | Ticker:
NASDAQ
20.11.26 | 16:05
46,270 US-Dollar
+3,63 % +1,620
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
HEARTFLOW INC Chart 1 Jahr
5-Tage-Chart
HEARTFLOW INC 5-Tage-Chart

Aktuelle News zur HEARTFLOW Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.11.Heartflow stock tumbles despite strong growth beating Q3 expectations-
13.11.Stifel raises HeartFlow stock price target to $70 on strong growth1
13.11.HeartFlow raises 2026 revenue outlook to $262M-$264M as Plaque nears 1,300 active accounts1
12.11.HeartFlow, Inc. Non-GAAP EPS of -$0.03 beats by $0.07, revenue of $72.86M beats by $7.66M1
12.11.Heartflow, Inc.: Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance2
12.11.Heartflow, Inc. - 10-Q, Quarterly Report-
HEARTFLOW Aktie jetzt für 0€ handeln
11.11.HeartFlow Q3 2026 Earnings Preview2
01.11.Heartflow, Inc.: TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients1
20.10.Piper Sandler raises HeartFlow stock price target on competitive moat6
19.10.Heartflow, Inc.: Heartflow to Report Third Quarter 2026 Financial Results on November 12, 20264
06.10.Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5%2.017SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is...
► Artikel lesen
29.09.AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion1
22.09.Canaccord raises HeartFlow stock price target on plaque analysis survey4
22.09.Canaccord hebt Kursziel für HeartFlow nach Plaque-Analyse-Umfrage an-
28.08.Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half 1.516FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting...
► Artikel lesen
25.08.Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow1.385WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx...
► Artikel lesen
21.08.Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD2
16.08.Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand4
15.08.Analysts Are Bullish on Heartflow (HTFL) Stock. Here's Why11
15.08.Why Heartflow Stock Soared Today2
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1